UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Determine the index fund with the lowest retirement cost through a concise comparison to guide a cost-aware choice.
28,256 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Intel staged a monster rally, narrowing the gap with AMD. This article breaks down what the surge means for investors...
Nearly 40% of Stanford undergraduates are registered with disability services, a surge linked to broader Gen Z trends...
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
A rare two-step upgrade on Intel hints at a shifting AI investment narrative. This article breaks down what it means ...
As EV demand grows and policy shifts unfold, investors are sizing up 2026. This guide breaks down the chances of a re...
AST SpaceMobile just completed a trio of successful BlueBird launches, yet spacemobile's stock down after the event. ...
Monster Beverage's 2025 earnings outlook centers on international growth, margin improvements, and strategic branding...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
When a tech giant pulls back from its peak, it creates both risk and opportunity. This guide breaks down why Meta Pla...
Meta Platforms faces a crossroads as AI investments collide with rising costs. Analysts see potential upside toward $...
A Supreme Court ruling blocks Trump’s emergency tariffs, leaving executives silent as refunds, labor concerns, and ma...